NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vivtex

Vivtex

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://vivtex.com/

Last Round

Accelerator

May 9, 2024

Total Funding Raised

$1.8M

Company Overview

Vivtex is a biotechnology company that operates a healthcare platform for drug development using robotic technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Industrial Robotics, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

oral biologicsdrug delivery platforminjectable to oraloral peptidesGI-ORIS platformdrug co-developmentrobotic screeninghigh-throughput screeningHTSoral absorption predictiondrug formulationGastrointestinal Organ Robotic Interface Systemex vivo screeningbiologic therapeuticsdrug development royalties

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivtex Comps

Public and private peers based on sector, stage, and business model.

Vivtex comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vivtex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 9, 2024
Convertible DebtAug 19, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Thomas von Erlach

Co-Founder And CEO

Founding Team

Vivtex Investors

Notable investors and investment history

Vivtex investors
InvestorRounds
The Elizabeth Elting Venture FundAccelerator
Endless Frontier LabsAccelerator
Portal InnovationsConvertible Debt
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2026

    Grew 17% QoQ, from 18 to 21 employees.

  • Jan 8, 2026

    Monthly visitors grew 222% MoM.

View all signals

Vivtex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vivtex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vivtex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range23
Year Founded2018
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.